The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines

Cancer Research

Volumn 63, Issue 9, 2003, Pages 2172-2178

  Grille, Sylvia Julien ^a   Bellacosa, Alfonso ^b   Upson, John ^b   Klein Szanto, Andres J ^b   Van Roy, Frans ^c   Lee Kwon, Whaseon ^d   Donowitz, Mark ^d   Tsichlis, Philip N ^e   Larue, Lionel ^a  

^a INSTITUT CURIE   (France)

^b FOX CHASE CANCER CENTER   (United States)

^c GHENT UNIVERSITY   (Belgium)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; DESMOPLAKIN; FIBRONECTIN; PROTEIN KINASE B; UVOMORULIN; VIMENTIN;

ARTICLE; BIOENGINEERING; CANCER CELL CULTURE; CANCER INVASION; CARCINOMA CELL; CELL ACTIVITY; CELL ADHESION; CELL MOTILITY; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MESENCHYME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; SURFACE PROPERTY; TRANSCRIPTION REGULATION; UPREGULATION;

BETA CATENIN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; DOWN-REGULATION; ENZYME ACTIVATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MESODERM; NEOPLASM INVASIVENESS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SUBCELLULAR FRACTIONS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION; VIMENTIN;

EID: 0037728809     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. DeVita, V. T., Hellman, S., and Rosenberg, S. A. Cancer: Principles and Practice of Oncology, 6th ed. New York: Lippincott-Raven, 2001.
2. Birchmeier, W., Hulsken, J., and Behrens, J. E-cadherin as an invasion suppressor. Ciba Found. Symp., 189: 124-136; discussion 136-141, 174-176, 1995.
3. Vleminckx, K., Vakaet, L., Jr., Mareel, M., Fiers, W., and van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66: 107-119, 1991.
4. Cano, A., Perez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., and Nieto, M. A. The transcription factor snail controls epithelialmesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol., 2: 76-83, 2000.
5. Batlle, E., Sancho, E., Franci, C., Dominguez, D., Monfar, M., Baulida, J., and Garcia De Herreros, A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol., 2: 84-89, 2000.
6. Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., and van Roy, F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell, 7: 1267-1278, 2001.
7. Woodhouse, E. C., Chuaqui, R. F., and Liotta, L. A. General mechanisms of metastasis. Cancer (Phila.), 80: 1529-1537, 1997.
8. Testa, J. R., and Bellacosa, A. AKT plays a central role in tumorigenesis. Proc. Natl. Acad. Sci. USA, 98: 10983-10985, 2001.
9. Cheng, J. Q., Godwin, A. K., Bellacosa, A., Taguchi, T., Franke, T. F., Hamilton, T. C., Tsichlis, P. N., and Testa, J. R. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. USA, 89: 9267-9271, 1992.
10. Bellacosa, A., de Feo, D., Godwin, A. K., Bell, D. W., Cheng, J. Q., Altomare, D. A., Wan, M., Dubeau, L., Scambia, G., Masciullo, V., et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int. J. Cancer, 64: 280-285, 1995.
11. Cheng, J. Q., Ruggeri, B., Klein, W. M., Sonoda, G., Altomare, D. A., Watson, D. K., and Testa, J. R. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. USA, 93: 3636-3641, 1996.
12. Ringel, M. D., Hayre, N., Saito, J., Saunier, B., Schuppert, F., Burch, H., Bemet, V., Burman, K. D., Kohn, L. D., and Saji, M. Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res., 61: 6105-6111, 2001.
13. Yuan, Z. Q., Sun, M., Feldman, R. I., Wang, G., Ma, X., Jiang, C., Coppola, D., Nicosia, S. V., and Cheng, J. Q. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene, 19: 2324-2330, 2000.
14. Nakayama, H., Ikebe, T., Beppu, M., and Shirasuna, K. High expression levels of nuclear factor κB, IκB kinase α, and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer (Phila.), 92: 3037-3044, 2001.
15. Sun, M., Wang, G., Paciga, J. E., Feldman, R. I., Yuan, Z. Q., Ma, X. L., Shelley, S. A., Jove, R., Tsichlis, P. N., Nicosia, S. V., and Cheng, J. Q. AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am. J. Pathol., 159: 431-437, 2001.
16. Brognard, J., Clark, A. S., Ni, Y., and Dennis, P. A. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res., 61: 3986-3997, 2001.
17. Plas, D. R., and Thompson, C. B. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol. Metab., 13: 75-78, 2002.
18. Tanno, S., Mitsuuchi, Y., Altomare, D. A., Xiao, G. H., and Testa, J. R. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res., 61: 589-593, 2001.
19. Park, B. K., Zeng, X., and Glazer, R. I. Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res., 61: 7647-7653, 2001.
20. Thant, A. A., Nawa, A., Kikkawa, F., Ichigotani, Y., Zhang, Y., Sein, T. T., Amin, A. R., and Hamaguchi, M. Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the P13K-Akt pathways in ovarian cancer cells. Clin. Exp. Metastasis, 18: 423-428, 2000.
21. Caamano, J., Zhang, S. Y., Rosvold, E. A., Bauer, B., and Klein-Szanto, A. J. p53 alterations in human squamous cell carcinomas and carcinoma cell lines. Am. J. Pathol., 142: 1131-1139, 1993.
22. Morali, O. G., Delmas, V., Moore, R., Jeanney, C., Thiery, J. P., and Larue, L. IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene, 20: 4942-4950, 2001.
23. Stratford-Perricaudet, L. D., Makeh, I., Perricaudet, M., and Briand, P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Investig., 90: 626-630, 1992.
24. Miller, A. D., and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques, 7: 980-990, 1989.
25. Landau, N. R., and Littman, D. R. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol., 66: 5110-5113, 1992.
26. Petit, V., Boyer, B., Lentz, D., Turner, C. E., Thiery, J. P., and Valles, A. M. Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells. J. Cell Biol., 148: 957-970, 2000.
27. Bassi, D. E., Mahloogi, H., Al-Saleem, L., Lopez De Cicco, R., Ridge, J. A., and Klein-Szanto, A. J. Elevated furin expression in aggressive human head and neck tumors and tumor cell lines. Mol. Carcinog., 31: 224-232, 2001.
28. Bassi, D. E., Lopez De Cicco, R., Mahloogi, H., Zucker, S., Thomas, G., and Klein-Szanto, A. J. Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells. Proc. Natl. Acad. Sci. USA, 98: 10326-10331, 2001.
29. + exchanger 3. J. Biol. Chem., 276: 31296-31304, 2001.
30. Bellacosa, A., Franke, T. F., Gonzalez-Portal, M. E., Datta, K., Taguchi, T., Gardner, J., Cheng, J. Q., Testa, J. R., and Tsichlis, P. N. Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications. Oncogene, 8: 745-754, 1993.
31. Ahmed, N. N., Franke, T. F., Bellacosa, A., Datta, K., Gonzalez-Portal, M. E., Taguchi, T., Testa, J. R., and Tsichlis, P. N. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene, 8: 1957-1963, 1993.
32. Nieto, M. A. The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell. Biol., 3: 155-166, 2002.
33. Behrens, J., Mareel, M. M., Van Roy, F. M., and Birchmeier, W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol., 108: 2435-2447, 1989.
34. Boyer, B., Valles, A. M., and Edme, N. Induction and regulation of epithelialmesenchymal transitions. Biochem. Pharmacol., 60: 1091-1099, 2000.
35. 1 subunit induces recognition of the RGDS sequence in fibronectin. J. Cell Biol., 126: 271-279, 1994.
36. Danen, E. H., and Yamada, K. M. Fibronectin, integrins, and growth control. J. Cell. Physiol., 189: 1-13, 2001.
37. Geiger, B., Bershadsky, A., Pankov, R., and Yamada, K. M. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat. Rev. Mol. Cell. Biol., 2: 793-805, 2001.
38. Piek, E., Moustakas, A., Kurisaki, A., Heldin, C. H., and ten Dijke, P. TGF-β type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J. Cell Sci., 112: 4557-4568, 1999.
39. Gavrilovic, J., Moens, G., Thiery, J. P., and Jouanneau, J. Expression of transfected transforming growth factor α induces a motile fibroblast-like phenotype with extracellular matrix-degrading potential in a rat bladder carcinoma cell line. Cell Regul., 1: 1003-1014, 1990.
40. Valles, A. M., Boyer, B., Badet, J., Tucker, G. C., Barritault, D., and Thiery, J. P. Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc. Natl. Acad. Sci. USA, 87: 1124-1128, 1990.
41. Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L., and Arteaga, C. L. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymatransition and cell migration. J. Biol. Chem., 275: 36803-36810, 2000.
42. Chan, T. O., Rodeck, U., Chan, A. M., Kimmelman, A. C., Rittenhouse, S. E., Panayotou, G., and Tsichlis, P. N. Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunit. Cancer Cell, 1: 181-191, 2002.
43. Morali, O. G., Jouneau, A., McLaughlin, K. J., Thiery, J. P., and Larue, L. IGF-II promotes mesoderm formation. Dev. Biol., 227: 133-145, 2000.
44. Barbieri, M. A., Kohn, A. D., Roth, R. A., and Stahl, P. D. Protein kinase B/akt and rab5 mediate Ras activation of endocytosis. J. Biol. Chem., 273: 19367-19370, 1998.
45. Woodman, P. G. Biogenesis of the sorting endosome: the role of Rab5. Traffic, 1: 695-701, 2000.
46. Polakis, P. Wnt signaling and cancer. Genes Dev., 14: 1837-1851, 2000.
47. Behrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature (Lond.), 382: 638-642, 1996.
48. Huber, O., Kom, R., McLaughlin, J., Ohsugi, M., Herrmann, B. G., and Kemler, R. Nuclear localization of β-catenin by interaction with transcription factor LEF-1. Mech. Dev., 59: 3-10, 1996.
49. Nusse, R. WNT targets. Repression and activation. Trends Genet., 15: 1-3, 1999.
50. 2+ pathways. Oncogene, 18: 7860-7872, 1999.
51. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature (Lond.), 378: 785-789, 1995.
52. Frame, S., Cohen, P., and Biondi, R. M. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell, 7: 1321-1327, 2001.
53. Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C., and Pearl, L. H. Crystal structure of glycogen synthase kinase 3β: structural basis for phosphateprimed substrate specificity and autoinhibition. Cell, 105: 721-732, 2001.
54. Weston, C. R., and Davis, R. J. Signal transduction: signaling specificity - a complex affair. Science (Wash. DC), 292: 2439-2440, 2001.
55. Fukumoto, S., Hsieh, C. M., Maemura, K., Layne, M. D., Yet, S. F., Lee, K. H., Matsui, T., Rosenzweig, A., Taylor, W. G., Rubin, J. S., Perrella, M. A., and Lee, M. E. Akt participation in the Wnt signaling pathway through Dishevelled. J. Biol. Chem., 276: 17479-17483, 2001.
56. Chen, R. H., Ding, W. V., and McCormick, F. Wnt signaling to β-catenin involves two interactive components. Glycogen synthase kinase-3β inhibition and activation of protein kinase C. J. Biol. Chem., 275: 17894-17899, 2000.
57. Ding, V. W., Chen, R. H., and McCormick, F. Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling. J. Biol. Chem., 275: 32475-32481, 2000.
58. Grevengoed, E. E., Loureiro, J. J., Jesse, T. L., and Peifer, M. Abelson kinase regulates epithelial morphogenesis in Drosophila. J. Cell Biol., 155: 1185-1198, 2001.
59. Larue, L., Antos, C., Butz, S., Huber, O., Delmas, V., Dominis, M., and Kemler, R. A role for cadherins in tissue formation. Development (Camb.), 122: 3185-3194, 1996.
60. Hemavathy, K., Ashraf, S. I., and Ip, Y. T. Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene (Amst.), 257: 1-12, 2000.
61. Delmas, V., Pla, P., Feracci, H., Thiery, J. P., Kemler, R., and Larue, L. Expression of the cytoplasmic domain of E-cadherin induces precocious mammary epithelial alveolar formation and affects cell polarity and cell-matrix integrity. Dev. Biol., 216: 491-506, 1999.
62. Lopez, T., and Hanahan, D. Elevated levels of IGF-I receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell, 1: 339-353, 2002.